Related references
Note: Only part of the references are listed.Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection
Armando Tripodi et al.
THROMBOSIS RESEARCH (2021)
Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti-phosphatidyl-serine/prothrombin antibodies to lupus anticoagulant activity
Maria Grazia Cattini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis
Armando Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection and interpretation
Katrien M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa
Emmanuel J. Favaloroa et al.
THROMBOSIS RESEARCH (2019)
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial
Josep Ordi-Ros et al.
ANNALS OF INTERNAL MEDICINE (2019)
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism
Clive Kearon et al.
BLOOD (2018)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study
A. Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Clinical utility of automated chemiluminescent antiphospholipid antibody assay
Teresa Iwaniec et al.
THROMBOSIS RESEARCH (2015)
Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent
O. Kumano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment
A. Tripodi et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Lupus Anticoagulant (LAC) testing in patients with inflammatory status: Does C-reactive protein interfere with LAC test results?
Sofie M. E. Schouwers et al.
THROMBOSIS RESEARCH (2010)
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: Considerations on the differentiation between the 2 circulating anticoagulants
A Tripodi et al.
CLINICAL CHEMISTRY (2005)
Share Paper
